All‐oral direct‐acting antiviral therapy in HCV‐advanced liver disease is effective in real‐world practice: observations through HCV‐TARGET database
Reddy, K. R., Lim, J. K., Kuo, A., Di Bisceglie, A. M., Galati, J. S., Morelli, G., Everson, G. T., Kwo, P. Y., Brown, R. S., Sulkowski, M. S., Akuschevich, L., Lok, A. S., Pockros, P. J., Vainorius, M., Terrault, N. A., Nelson, D. R., Fried, M. W., Manns, M. P.
Published in Alimentary pharmacology & therapeutics (01.01.2017)
Published in Alimentary pharmacology & therapeutics (01.01.2017)
Get full text
Journal Article
Association of a polymorphism in the indoleamine- 2,3-dioxygenase gene and interferon-α-induced depression in patients with chronic hepatitis C
SMITH, A. K, SIMON, J. S, SULKOWSKI, M. S, MCHUTCHINSON, J. G, MILLER, A. H, GUSTAFSON, E. L, NOVIELLO, S, CUBELLS, J. F, EPSTEIN, M. P, DEVLIN, D. J, QIU, P, ALBRECHT, J. K, BRASS, C. A
Published in Molecular psychiatry (01.08.2012)
Published in Molecular psychiatry (01.08.2012)
Get full text
Journal Article
Efficacy and safety of 6 or 8 weeks of simeprevir, daclatasvir, sofosbuvir for HCV genotype 1 infection
Sulkowski, M. S., Feld, J. J., Lawitz, E., Felizarta, F., Corregidor, A. M., Khalid, O., Ghalib, R., Smith, W. B., Van Eygen, V., Luo, D., Vijgen, L., Gamil, M., Kakuda, T. N., Ouwerkerk‐Mahadevan, S., Van Remoortere, P., Beumont, M.
Published in Journal of viral hepatitis (01.06.2018)
Published in Journal of viral hepatitis (01.06.2018)
Get full text
Journal Article
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
Afdhal, N. H., Zeuzem, S., Schooley, R. T., Thomas, D. L., Ward, J. W., Litwin, A. H., Razavi, H., Castera, L., Poynard, T., Muir, A., Mehta, S. H., Dee, L., Graham, C., Church, D. R., Talal, A. H., Sulkowski, M. S., Jacobson, I. M.
Published in Journal of viral hepatitis (01.11.2013)
Published in Journal of viral hepatitis (01.11.2013)
Get full text
Journal Article
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin
Gordon, S. C., Yoshida, E. M., Lawitz, E. J., Bacon, B. R., Sulkowski, M. S., Davis, M., Poordad, F., Bronowicki, J.‐P., Esteban, R., Sniukiene, V., Burroughs, M. H., Deng, W., Dutko, F. J., Brass, C. A., Albrecht, J. K., Rajender Reddy, K.
Published in Alimentary Pharmacology & Therapeutics (Suppl) (01.07.2013)
Published in Alimentary Pharmacology & Therapeutics (Suppl) (01.07.2013)
Get full text
Journal Article
Hepatotoxicity Associated With Antiretroviral Therapy in Adults Infected With Human Immunodeficiency Virus and the Role of Hepatitis C or B Virus Infection
Sulkowski, Mark S, Thomas, David L, Chaisson, Richard E, Moore, Richard D
Published in JAMA : the journal of the American Medical Association (05.01.2000)
Published in JAMA : the journal of the American Medical Association (05.01.2000)
Get full text
Journal Article
Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population
Rodriguez-Torres, M., Sulkowski, M. S., Chung, R. T., Hamzeh, F. M., Jensen, D. M.
Published in Journal of viral hepatitis (01.02.2010)
Published in Journal of viral hepatitis (01.02.2010)
Get full text
Journal Article
Hepatitis C treatment among racial and ethnic groups in the IDEAL trial
Muir, A. J., Hu, K. -Q., Gordon, S. C., Koury, K., Boparai, N., Noviello, S., Albrecht, J. K., Sulkowski, M. S., McCone, J.
Published in Journal of viral hepatitis (01.04.2011)
Published in Journal of viral hepatitis (01.04.2011)
Get full text
Journal Article
Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response
Clark, P. J., Thompson, A. J., Zhu, M., Vock, D. M., Zhu, Q., Ge, D., Patel, K., Harrison, S. A., Urban, T. J., Naggie, S., Fellay, J., Tillmann, H. L., Shianna, K., Noviello, S., Pedicone, L. D., Esteban, R., Kwo, P., Sulkowski, M. S., Afdhal, N., Albrecht, J. K., Goldstein, D. B., McHutchison, J. G., Muir, A. J.
Published in Journal of viral hepatitis (01.05.2012)
Published in Journal of viral hepatitis (01.05.2012)
Get full text
Journal Article
Understanding and addressing hepatitis C reinfection in the oral direct‐acting antiviral era
Falade‐Nwulia, O., Sulkowski, M. S., Merkow, A., Latkin, C., Mehta, S. H.
Published in Journal of viral hepatitis (01.03.2018)
Published in Journal of viral hepatitis (01.03.2018)
Get full text
Journal Article
Public health clinic-based hepatitis C testing and linkage to care in baltimore
Falade-Nwulia, O., Mehta, S. H., Lasola, J., Latkin, C., Niculescu, A., O'Connor, C., Chaulk, P., Ghanem, K., Page, K. R., Sulkowski, M. S., Thomas, D. L.
Published in Journal of viral hepatitis (01.05.2016)
Published in Journal of viral hepatitis (01.05.2016)
Get full text
Journal Article
Primary Care Providers Knowledge, Attitude and Practices Related to Hepatitis C Screening and Treatment in the Oral Direct Acting Antiviral Agents Era
Falade-Nwulia, O, McAdams-Mahmoud, A, Irvin, R, Niculescu, A, Page, K R, Mix, M, Thomas, D L, Sulkowski, M S, Mehta, S H
Published in Journal of community medicine & health education (01.10.2016)
Published in Journal of community medicine & health education (01.10.2016)
Get full text
Journal Article
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir
Sterling, R. K., Kuo, A., Rustgi, V. K., Sulkowski, M. S., Stewart, T. G., Fenkel, J. M., El‐Genaidi, H., Mah'moud, M. A., Abraham, G. M., Stewart, P. W., Akushevich, L., Nelson, D. R., Fried, M. W., Di Bisceglie, A. M.
Published in Alimentary pharmacology & therapeutics (01.04.2015)
Published in Alimentary pharmacology & therapeutics (01.04.2015)
Get full text
Journal Article